GeoVax Labs, Inc. New (GOVX)
GeoVax Labs, Inc. is a biotechnology company focused on developing innovative vaccines and immunotherapies for infectious diseases and cancers. The company leverages its proprietary MVA-VLP (Modified Vaccinia Ankara-Virus-Like Particle) platform to create candidates aimed at HIV, Ebola, Zika, and COVID-19, among others. GeoVax aims to advance its vaccine candidates through clinical trials to address unmet medical needs globally.
Company News
Several biotech companies are advancing cancer research with promising clinical milestones, focusing on innovative immunotherapies and targeted treatments amid rising cancer incidence and potential research funding challenges.
EmergingGrowth.com announced the schedule for its 84th conference featuring presentations from multiple public companies across technology, biotech, and other sectors on July 16-17, 2025.
Read this before investing in penny stocks The post Investing in Penny Stocks With $1k, What to Know appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Hopes that the Federal Reserve may be less aggressive in hiking borrowing costs than previously feared have rippled swiftly across markets in the past week. Stocks have rallied as bond yields have dropped. And it has brought the dollar’s rampage to a juddering halt.